financetom
Technology
financetom
/
Technology
/
AGS Health Named 2026 Top Clinical Denial and Appeal Management Services Vendor by Black Book Research
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AGS Health Named 2026 Top Clinical Denial and Appeal Management Services Vendor by Black Book Research
Aug 6, 2026 10:19 AM

WASHINGTON, D.C. / ACCESS Newswire / August 6, 2026 / AGS Health®, a leading provider of technology-first revenue cycle management (RCM) solutions serving healthcare providers across the U.S. through a comprehensive platform combining AI-driven solutions, data analytics, and specialized global delivery capabilities, has been named the top clinical denial and appeal management services vendor for 2026 by Black Book Research, the healthcare industry's independent source for crowdsourced IT and outsourcing performance insights. The ranking was published in Black Book's 2026 State of Health & Hospital Systems Revenue Cycle Management Technology & Services report, which evaluates client-ranked RCM software, services, and technology-enabled operations vendors nationwide.

The AGS Health approach to clinical denial and appeal management involves reviewing and classifying denial reasons, identifying denial root causes, and submitting appeals with appropriate supporting documentation to recover lost revenue. Under this physician-led model, AI enhances the process, subject to defined quality controls and human review for exceptions and complex clinical matters.

Black Book's rankings are based solely on client feedback, with scoring designed to reflect current-year performance indicators, including workflow fit, implementation reliability, user adoption, operational impact, auditability, support responsiveness, and measurable financial value. The 2026 report evaluates 420 RCM vendors across 18 qualitative KPIs in 49 ranked offering categories. It features an expanded methodology emphasizing payer-friction detection, preventable-denial logic, prior authorization requirement detection and evidence assembly, human-in-the-loop AI controls, model observability, and audit trail transparency.

"This Black Book ranking reflects the confidence our clients place in AGS Health's ability to address increasingly complex clinical denials, which have emerged as one of the fastest growing and most challenging problems in healthcare RCM," said Cheryl Cruver, President of U.S. Markets and Chief Commercial Officer, AGS Health. "Today's healthcare organizations, including 74% of Black Book survey respondents, are now prioritizing denial prevention over post-denial recovery. We support this transition by coupling clinical expertise with operational efficiency, and we're honored to be recognized for the measurable impact this model is delivering."

AGS Health intends to maintain its position as a technology leader in the RCM industry by continuing to invest in AI, ML, natural language processing, and automation capabilities as part of its broader clinical administrative services. In doing so, the company will enhance its ability to help healthcare organizations improve denial prevention, strengthen reimbursement performance, and reduce administrative burden while maintaining defined quality controls.

The complete list of top RCM vendors can be found here.

About AGS Health

AGS Health serves large health systems, physician groups, and hospitals across the U.S. The company's approach combines technology-enabled revenue cycle services, intelligent automation, and customer support across front-end, mid-cycle, and back-end revenue cycle workflows, including patient financial engagement. AGS Health employs a team of approximately 16,000 employees supporting customers across diverse care settings and specialties. For more information, visit www.agshealth.com

# # #

Media Contact

Liz Goar

[email protected]

SOURCE: AGS Health

View the original press release on ACCESS Newswire

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
End of day crude oil price forecast update - 27-03-2024
End of day crude oil price forecast update - 27-03-2024
Mar 27, 2024
Crude oil price trades positively to approach 82.00$ barrier, and as long as the price is below 82.65$, our bearish overview will remain valid for the upcoming period, depending on the formation of double top pattern that supports the chances of achieving our targets that start at 80.86$ and extend to 78.90$ after breaking the previous level. ...
New AI benchmark tests speed of responses to user queries
New AI benchmark tests speed of responses to user queries
Mar 27, 2024
SAN FRANCISCO, March 27 (Reuters) - Artificial intelligence benchmarking group MLCommons on Wednesday released a fresh set of tests and results that rate the speed at which top-of-the-line hardware can run AI applications and respond to users. The two new benchmarks added by MLCommons measure the speed at which the AI chips and systems can generate responses from the powerful...
End of day gold price forecast update - 27-03-2024
End of day gold price forecast update - 27-03-2024
Mar 27, 2024
Gold price resumes its positive trading to approach 2200.00$ barrier, reinforcing the expectations of continuing the main bullish trend, supported by the positivity of the major indicators, reminding you that our first main target is located at 2222.86$, while achieving it requires holding above 2166.50$. ...
6 Analysts Assess Cleanspark: What You Need To Know
6 Analysts Assess Cleanspark: What You Need To Know
Mar 27, 2024
Throughout the last three months, 6 analysts have evaluated Cleanspark ( CLSK ) , offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...
Copyright 2023-2026 - www.financetom.com All Rights Reserved